Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has cleared Hope Pharmaceuticals' Sodium Nitrite Injection for use with sodium thiosulfate for the treatment of cyanide poisoning.
Subscribe to our email newsletter
Sodium Nitrite Injection (NDC 60267-311-10) is packaged in a 10mL vial containing 300mg of sodium nitrite.
The sodium nitrite injection is approved for use in children and adults, the company said.
To meet the new FDA-imposed requirements, the company utilizes custom-manufactured, ultra-pure sodium nitrite as the ingredient in its FDA-approved medication.
Hope Pharmaceuticals medical director Craig Sherman said doctors can now use an FDA-approved Sodium Nitrite Injection that complies with 2012 quality standards.